N/A
Completed N=60
Music Therapy in Acute Leukemia Patients With Fatigue
Source: ClinicalTrials.gov NCT06286332 ↗Enrolled (actual)
60
Serious AEs
8.3%
Results posted
Jan 2026
Primary outcomePrimary: Fatigue Score on the Tang Fatigue Rating Scale (TFRS) . — 106.96; 128.46 scores
Summary
The objective of this study is to assess the efficacy of employing music therapy in alleviating fatigue and medical laboratory values among patients with acute myeloid leukemia.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Fatigue Score on the Tang Fatigue Rating Scale (TFRS) . |
106.96; 128.46 | — |
| PRIMARY 11-point Numeric Rating Scale (NRS-11). |
4.07; 5.00 | — |
| SECONDARY Absolute Neutrophil Count (ANC) at Day 21. |
2456.32; 1373.60 | — |
| SECONDARY Hemoglobin Level at Day 21. |
9.30; 8.19 | — |
| SECONDARY Albumin Level at Day 21. |
3.87; 3.49 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosed with acute myeloid leukemia by a clinical specialist.
- Patients undergoing chemotherapy for the first time.
- Aged 18 years or older, capable of communicating in Mandarin or Taiwanese.
- Normal hearing ability.
- No history of psychiatric disorders and clear consciousness.
- Participants with no prior involvement in any intervention studies related to fatigue management.
- Demonstrates understanding of the research objectives, willingly participates in the study, and completes the informed consent form.
- Willing to cooperate with study procedures throughout the research period.
Exclusion Criteria
- Severe hearing impairment.
- Individuals with unstable vital signs or altered consciousness.
Data sourced from ClinicalTrials.gov (NCT06286332). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.